Paige Burnham, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 90 Tiger St, Saint Regis, MT 59866 Phone: 406-649-2311 |
News Archive
MX Orthopedics Corp. is a privately held company focused on improving implant/bone fixation. MXO is proud to announce the recent FDA clearance (K153129) of the dynaMX Compression Staple (patent pending). MXO's dynaMX line of fracture fixation implants include: superelastic compression staples, screws, plates, and intramedullary implants.
A new study shows the employment and sociodemographic characteristics involved in the exposure of pregnant women to workplace hazards. Of these, 56% say they often work standing up or have to lift heavy objects, 63% are exposed to workplace stress and 62% say they are frequently exposed to some physical risk in their place of work.
Healthcare that implements a person-centred approach not only make care more efficient, but also yields more satisfied patients. A study carried out at the Sahlgrenska Academy at the University of Gothenburg, Sweden, shows that if there is an active partnership between the patient and healthcare professionals, the patient's hospital stay can be reduced by one-third.
Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association.
Pfizer Inc. announced today the discontinuation of the SUN 1120 Phase 3 trial evaluating SUTENT (sunitinib malate) in combination with prednisone for men with advanced castration-resistant prostate cancer that had progressed despite treatment with a docetaxel-based chemotherapy regimen. During a scheduled interim analysis, an independent Data Monitoring Committee found that the combination of sunitinib with prednisone was unlikely to improve overall survival when compared to prednisone alone.
› Verified 7 days ago